Important information for healthcare providers and the public included in updated FDA Emergency Use Authorization Fact Sheets
More
The Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the distribution of the Johnson & Johnson COVID-19 vaccine after six women between the ages of 18 and 48 experienced clotting six to 13 days after vaccination.
More
The largest American companies are deeply involved in the economy of the United States, as well as the rest of the world. The 20 largest publicly traded US companies, top constituents of the S&P 500 index, are presented here together with their activities, logos, and useful links.
More
The UN World Health Organization (WHO) said on Friday that it was aware of blood clot concerns linked to “a specific batch” of AstraZeneca/Oxford COVID-19 vaccine, but maintained that to date, no-one has died from any coronavirus vaccine.
More
The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More
The FDA confirmed Emergency Use Authorization after reviewing the safety and efficacy of Johnson & Johnson's vaccine. Here's what you need to know.
More
The U.S. Food and Drug Administration formally authorized the use of the Johnson & Johnson’s one-dose vaccine Saturday, clearing the way for shots to go into arms as early as Monday.
More
Today, the European Commission approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
More